Cargando…

Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice

BACKGROUND: Recent epidemiological evidence suggests that modifying lifestyle by increasing physical activity could be a non-pharmacological approach to improving symptoms and slowing disease progression in Alzheimer’s disease and other tauopathies. Previous studies have shown that exercise reduces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohia-Nwoko, Odochi, Montazari, Saghi, Lau, Yuen-Sum, Eriksen, Jason L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280713/ https://www.ncbi.nlm.nih.gov/pubmed/25432085 http://dx.doi.org/10.1186/1750-1326-9-54

Ejemplares similares

Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
por: Womack, Tasha R., et al.
Publicado: (2022)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
por: Höllerhage, Matthias, et al.
Publicado: (2014)

Correction: Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
Publicado: (2015)

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
por: Hosokawa, Masato, et al.
Publicado: (2012)

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
por: Zhong, Suyue, et al.
Publicado: (2023)

Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
por: Schön, Christian, et al.
Publicado: (2012)

Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in Tau(P301L)-BiFC mice
por: Lim, Sungsu, et al.
Publicado: (2023)

Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
por: Bi, Mian, et al.
Publicado: (2011)

Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
por: Schweighauser, Manuel, et al.
Publicado: (2023)

Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
por: Hoffmann, Nadine A, et al.
Publicado: (2013)

Altered sleep and EEG power in the P301S Tau transgenic mouse model
por: Holth, Jerrah K., et al.
Publicado: (2017)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
por: Eckenweber, Florian, et al.
Publicado: (2020)

Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
por: Mazzaro, Nadia, et al.
Publicado: (2013)

Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord
por: Macdonald, Jennifer A., et al.
Publicado: (2019)

Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons
por: Rodríguez-Martín, Teresa, et al.
Publicado: (2016)

Alteration in the Synaptic and Extrasynaptic Organization of AMPA Receptors in the Hippocampus of P301S Tau Transgenic Mice
por: Alfaro-Ruiz, Rocio, et al.
Publicado: (2022)

Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice
por: Giannopoulos, Phillip F., et al.
Publicado: (2018)

Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice
por: van der Hoven, Julia, et al.
Publicado: (2020)

Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice
por: Alfaro‐Ruiz, Rocío, et al.
Publicado: (2022)

Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
por: Zhao, Shuai, et al.
Publicado: (2022)

Longitudinal evaluation of Tau‐P301L transgenic mice reveals no cognitive impairments at 17 months of age
por: Kent, Brianne A., et al.
Publicado: (2017)

Commentary: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
por: Betts, Matthew J., et al.
Publicado: (2018)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

The Change in Circadian Rhythms in P301S Transgenic Mice is Linked to Variability in Hsp70-related Tau Disaggregation
por: Han, Song Mi, et al.
Publicado: (2022)

Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits
por: Harris, Julie A., et al.
Publicado: (2012)

Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
por: Kunze, Lea Helena, et al.
Publicado: (2023)

Repetitive Traumatic Brain Injury Causes Neuroinflammation before Tau Pathology in Adolescent P301S Mice
por: Izzy, Saef, et al.
Publicado: (2021)

Tau Protein Modulates Perineuronal Extracellular Matrix Expression in the TauP301L-acan Mouse Model
por: Schmidt, Sophie, et al.
Publicado: (2022)

Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation
por: Richter, Monique, et al.
Publicado: (2014)

P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
por: Ruan, Zhi, et al.
Publicado: (2020)

Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

Fyn depletion ameliorates tau(P301L)-induced neuropathology
por: Liu, Guanghao, et al.
Publicado: (2020)

Human TAU(P301L) overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain
por: Cosacak, Mehmet I., et al.
Publicado: (2017)

Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates
por: Brelstaff, Jack H., et al.
Publicado: (2021)

P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
por: Takeuchi, Hiroki, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1t0c8d1npuu34nsklq38spm4n6